Literature DB >> 17580343

The fine needle aspiration biopsy diagnostic criteria of proliferative breast lesions: a retrospective statistical analysis of criteria for papillomas and radial scar lesions.

Andrew Field1, Alison Mak.   

Abstract

This study aimed to analyze statistically the accuracy of fine needle aspiration biopsy cytological criteria in diagnosing epithelial hyperplasia with atypia (EHA), papillary lesions (PAP), and radial scar/complex sclerosing lesions (RS/CSL). The 42 criteria studied were extracted from a literature review and those developed and used in our department. Cytological cases with diagnoses of EHA, PAP, and RS/CSL for the period of 1997-2001 were correlated with relevant histological follow-up and the positive predictive power of these diagnoses have been presented in an earlier publication. Some 77 cases with definite, specific histological diagnoses of atypia or a more severe lesion, PAP and RS/CSL, were reviewed and scored using 55 cytological criteria. As the group of EHA and RS/CSL yielded a smaller number of cases, these were grouped together in the statistical analysis and compared to PAP. The cytological features, which were most diagnostic for PAP, were stellate (Odds ratio 1.75) and meshwork (Odds ratio 3.29) tissue fragments, while the presence of tubular structures was inversely proportional to the histological outcome of PAP. True papillary fragments were uncommon and not statistically significant in diagnosing PAP of the breast.

Entities:  

Mesh:

Year:  2007        PMID: 17580343     DOI: 10.1002/dc.20652

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

Review 1.  Grey zone lesions of breast: Potential areas of error in cytology.

Authors:  Suvradeep Mitra; Pranab Dey
Journal:  J Cytol       Date:  2015 Jul-Sep       Impact factor: 1.000

2.  How Accurately FNAC Reflects the Breast Papillary Lesions?

Authors:  Gülistan Gümrükçü; Meryem Doğan; Nilüfer Gürsan; Barış Boylu; Erhan Ekren; Fügen Vardar Aker
Journal:  J Cytol       Date:  2022-02-17       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.